News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
659,548 Results
Type
Article (48296)
Company Profile (395)
Press Release (610857)
Multimedia
Podcasts (96)
Webinars (12)
Section
Business (179723)
Career Advice (3128)
Deals (32500)
Drug Delivery (105)
Drug Development (80404)
Employer Resources (176)
FDA (15473)
Job Trends (13749)
News (314449)
Policy (30043)
Tag
Academia (2735)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (88)
Alliances (45935)
ALS (97)
Alzheimer's disease (1448)
Antibody-drug conjugate (ADC) (148)
Approvals (15442)
Artificial intelligence (267)
Autoimmune disease (28)
Automation (14)
Bankruptcy (308)
Best Places to Work (11153)
BIOSECURE Act (18)
Biosimilars (102)
Biotechnology (307)
Bladder cancer (84)
Brain cancer (31)
Breast cancer (299)
Cancer (2377)
Cardiovascular disease (193)
Career advice (2641)
Career pathing (33)
CAR-T (175)
Cell therapy (491)
Cervical cancer (20)
Clinical research (65298)
Collaboration (883)
Company closure (1)
Compensation (544)
Complete response letters (27)
COVID-19 (2548)
CRISPR (49)
C-suite (261)
Cystic fibrosis (108)
Data (2304)
Decentralized trials (2)
Denatured (28)
Depression (52)
Diabetes (285)
Diagnostics (5899)
Digital health (18)
Diversity (6)
Diversity, equity & inclusion (43)
Drug discovery (128)
Drug pricing (108)
Drug shortages (31)
Duchenne muscular dystrophy (104)
Earnings (71183)
Editorial (45)
Employer branding (22)
Employer resources (153)
Events (111551)
Executive appointments (724)
FDA (16802)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (783)
Gene editing (121)
Generative AI (24)
Gene therapy (363)
GLP-1 (767)
Government (4357)
Grass and pollen (5)
Guidances (117)
Healthcare (18449)
Huntington's disease (24)
IgA nephropathy (30)
Immunology and inflammation (140)
Indications (30)
Infectious disease (2685)
Inflammatory bowel disease (155)
Inflation Reduction Act (11)
Influenza (50)
Intellectual property (101)
Interviews (609)
IPO (15545)
IRA (43)
Job creations (3043)
Job search strategy (2164)
Kidney cancer (10)
Labor market (38)
Layoffs (461)
Leadership (23)
Legal (6727)
Liver cancer (76)
Lung cancer (328)
Lymphoma (156)
Machine learning (8)
Management (62)
Manufacturing (333)
MASH (76)
Medical device (12338)
Medtech (12342)
Mergers & acquisitions (17549)
Metabolic disorders (746)
Multiple sclerosis (81)
NASH (22)
Neurodegenerative disease (106)
Neuropsychiatric disorders (33)
Neuroscience (2028)
NextGen: Class of 2025 (6452)
Non-profit (4392)
Now hiring (32)
Obesity (398)
Opinion (263)
Ovarian cancer (78)
Pain (102)
Pancreatic cancer (82)
Parkinson's disease (157)
Partnered (21)
Patents (238)
Patient recruitment (114)
Peanut (48)
People (52617)
Pharmaceutical (76)
Pharmacy benefit managers (21)
Phase I (20479)
Phase II (28857)
Phase III (21562)
Pipeline (1308)
Policy (156)
Postmarket research (2403)
Preclinical (8687)
Press Release (72)
Prostate cancer (113)
Psychedelics (37)
Radiopharmaceuticals (265)
Rare diseases (425)
Real estate (5375)
Recruiting (70)
Regulatory (21132)
Reports (35)
Research institute (2387)
Resumes & cover letters (502)
Rett syndrome (5)
RNA editing (5)
RSV (39)
Schizophrenia (79)
Series A (132)
Series B (91)
Service/supplier (9)
Sickle cell disease (59)
Special edition (18)
Spinal muscular atrophy (154)
Sponsored (33)
Startups (3360)
State (2)
Stomach cancer (16)
Supply chain (68)
Tariffs (42)
The Weekly (67)
Vaccines (676)
Venture capitalists (42)
Weight loss (273)
Women's health (31)
Worklife (20)
Date
Today (300)
Last 7 days (887)
Last 30 days (2954)
Last 365 days (33008)
2025 (11525)
2024 (35341)
2023 (39804)
2022 (50523)
2021 (54809)
2020 (52578)
2019 (45159)
2018 (34180)
2017 (31796)
2016 (31310)
2015 (36390)
2014 (28868)
2013 (23700)
2012 (24927)
2011 (25692)
2010 (23830)
Location
Africa (870)
Alabama (54)
Alaska (6)
Arizona (185)
Arkansas (14)
Asia (38000)
Australia (6567)
California (6224)
Canada (2002)
China (538)
Colorado (261)
Connecticut (274)
Delaware (154)
Europe (87734)
Florida (906)
Georgia (201)
Idaho (52)
Illinois (551)
India (26)
Indiana (287)
Iowa (10)
Japan (167)
Kansas (100)
Kentucky (24)
Louisiana (12)
Maine (59)
Maryland (858)
Massachusetts (4839)
Michigan (232)
Minnesota (387)
Mississippi (2)
Missouri (86)
Montana (27)
Nebraska (24)
Nevada (57)
New Hampshire (61)
New Jersey (1737)
New Mexico (29)
New York (1750)
North Carolina (1034)
North Dakota (8)
Northern California (2719)
Ohio (205)
Oklahoma (14)
Oregon (34)
Pennsylvania (1393)
Puerto Rico (11)
Rhode Island (33)
South America (1169)
South Carolina (23)
Southern California (2333)
Tennessee (89)
Texas (901)
United States (23475)
Utah (172)
Virginia (151)
Washington D.C. (60)
Washington State (577)
West Virginia (3)
Wisconsin (53)
659,548 Results for "the lubrizol corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Lubrizol Licenses Award-Winning Apisolex™ Excipient to Welton Pharma to Develop a Novel Cancer Therapeutic
The Lubrizol Corporation announces the licensing of its novel excipient polymer technology, Apisolex™ excipient, to Welton Pharma (Welton).
June 20, 2023
·
3 min read
Business
Solecta® partners with Lubrizol® to bring novel membrane separation solutions to market
Solecta, Inc. and The Lubrizol Corporation announced a new partnership today to develop and market novel membrane solutions that will improve productivity and drive greater efficiencies for the global separations industry.
February 16, 2023
·
3 min read
Business
Rebecca Liebert Named President and CEO of Lubrizol
The Lubrizol Corporation, a Berkshire Hathaway Company, announced that Rebecca Liebert has been named the company’s President and CEO, effective October 3, 2022.
September 1, 2022
·
3 min read
Business
Mary Rhinehart Named Interim President and CEO of Lubrizol
The Lubrizol Corporation announced that Mary Rhinehart will serve as president and CEO on an interim basis, effective immediately.
March 11, 2022
·
1 min read
Press Releases
MiNK Therapeutics to Provide Corporate Update and First Quarter 2025 Financial Report
May 5, 2025
·
2 min read
Press Releases
United Therapeutics Corporation Reports First Quarter 2025 Financial Results
April 30, 2025
·
11 min read
Press Releases
Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates
May 6, 2025
·
9 min read
Press Releases
CORCEPT THERAPEUTICS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
May 5, 2025
·
11 min read
Press Releases
LENZ Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
May 8, 2025
·
8 min read
Press Releases
Rakovina Therapeutics Inc. Announces 2024 Financial Results and Provides Corporate Update
April 30, 2025
·
8 min read
1 of 65,955
Next
